[Comparative yearly growth rate of children with mucoviscidosis treated and not treated with ciprofloxacin:clinicomorphological comparisons].
The results of the prospective and comparative investigation of the linear growth of children at the age of 4 to 16 years with mucoviscidosis treated with ciprofloxacin in combination with a cephalosporin or an aminoglycoside in the main group and a cephalosporin or an aminoglycoside alone in the control group are presented. The children were observed for 3 and 5 years. It was shown that in spite of the treatment term with ciprofloxacin the yearly growth rate in the children in the main and control groups did not significantly differ. The morphological investigation did not reveal any injury of the armicular cartilage and growth zone. The hyperplastic reaction in the tegmental cartilage was states and considered as a physiological one in response to the presence of ciprofloxacin and therefore reversible. No chondrotoxicity of the fluoroquinolones and ciprofloxacin, particularly in the children, is explained.
Postnikov
C C
CC
Russian State Medical University, Moscow.
Semiakin
S I
SI
Nazhimov
V P
VP
Kapranov
N I
NI
D000293:Adolescent; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002358:Cartilage, Articular / Q000187:drug effects / Q000254:growth & development; D002648:Child; D002675:Child, Preschool; D002939:Ciprofloxacin / Q000627:therapeutic use*; D003550:Cystic Fibrosis / Q000150:complications* / Q000188:drug therapy* / Q000401:mortality; D004359:Drug Therapy, Combination; D006128:Growth / Q000187:drug effects*; D006132:Growth Plate / Q000187:drug effects; D006801:Humans; D007719:Knee Joint / Q000187:drug effects / Q000254:growth & development; D011446:Prospective Studies
D000890:Anti-Infective Agents; D002939:Ciprofloxacin